Table of abbreviations
| TERM | DESCRIPTION |
|---|---|
| 3R principles | replacement, reduction and refinement (animal testing) |
| AI | artificial intelligence |
| AMA | African Medicines Agency |
| AMQF | African Medicines Quality Forum |
| AMRH | African Medicines Regulatory Harmonisation |
| ANSM | French National Agency for Medicines and Health Products Safety (Agence nationale de sécurité du médicament et des produits de santé) |
| API | active pharmaceutical ingredient |
| ASMF | Active Substance Master File |
| ATD | anti-tampering device |
| B-MJV | Blood Mutual Joint Visit |
| B-PTS | Blood Proficiency Testing Scheme |
| B-QM | Blood Quality Management Programme |
| BRP | biological reference preparation |
| BSP | Biological Standardisation Programme |
| B-TES | Blood Tailored Expert Support |
| B-TV | Blood Training Visit |
| CAP | centrally authorised product |
| CAS number | Chemical Abstracts Service Registry number |
| CD-P-COS | European Committee for Cosmetics and Consumer Health |
| CD-P-MCA | European Committee for Food Contact Materials and Articles |
| CD-P-PH | European Committee on Pharmaceuticals and Pharmaceutical Care |
| CD-P-PH/CMED | Committee of Experts on Minimising the Public Health Risks Posed by Falsification of Medical Products and Similar Crimes |
| CD-P-PH/PC | Committee of Experts on Quality and Safety Standards in Pharmaceutical Practices and Pharmaceutical Care |
| CD-P-PH/PHO | Committee of Experts on the Classification of Medicines as Regards their Supply |
| CD-P-TO | European Committee on Organs, Tissues and Cells |
| CD-P-TS | European Committee on Blood Transfusion |
| CEP | Certificate of Suitability to the European Pharmacopoeia monographs |
| CLP | Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures |
| COS MSS | cosmetics market surveillance study |
| COS PTS | cosmetics proficiency testing scheme |
| COVID-19 | coronavirus disease |
| CRS | chemical reference substance |
| DCD | donation after circulatory death |
| DCP | decentralised procedure |
| DG SANTE | Directorate General for Health and Food Safety |
| DMF | Drug Master File |
| DNA | deoxyribonucleic acid |
| EAHP | European Association of Hospital Pharmacists |
| ECHA | European Chemicals Agency |
| EDA | Egyptian Drug Authority |
| EDD | European Donation Day |
| EDQM | European Directorate for the Quality of Medicines & HealthCare |
| EDSForm | European Drug Shortages Formulary |
| EDSForm WP | European Drug Shortages Formulary Working Party |
| EEA | European Economic Area |
| EFSA | European Food Safety Authority |
| EFTA | European Free Trade Association |
| EHMA | European Health Management Association |
| EMA | European Medicines Agency |
| EPC | European Pharmacopoeia Commission |
| ESCP | European Society of Clinical Pharmacy |
| EU | European Union |
| FIP | International Pharmaceutical Federation |
| GEON | General European OMCL Network |
| GMP | good manufacturing practice |
| HBc | hepatitis B core antigen |
| HBsAg | hepatitis B surface antigen |
| HCV | hepatitis C virus |
| HIV | human immunodeficiency virus |
| HMA | Heads of Medicines Agencies |
| HMA-WGEO | EU Heads of Medicines Agencies’ Working Group of Enforcement Officers |
| HTS | high-throughput sequencing (see also NGS) |
| HZJZ | Hrvatski zavod za javno zdravstvo Croatian Institute of Public Health |
| IgG | immunoglobulin |
| IPC | Indian Pharmacopoeia Commission |
| IR | infrared |
| ISA | International Standards for Antibiotics |
| ISBT | International Society of Blood Transfusion |
| IVDR | Regulation (EU) 2017/746 on in vitro diagnostic medical devices |
| JP | Japanese Pharmacopoeia |
| LAL | limulus amoebocyte lysate |
| LNA | Laboratory of Dutch Pharmacists (Farmaceutisch Laboratorium) |
| LNP | lipid nanoparticle |
| mAb | monoclonal antibody |
| MAT | monocyte-activation test |
| MDR | Regulation (EU) 2017/745 on medical devices |
| MJA | Mutual Joint Audit |
| MJV | Mutual Joint Visit |
| mRNA | messenger ribonucleic acid |
| MRP | Mutual Recognition Procedure |
| MSS | market surveillance study |
| NAT | nucleic amplification technique |
| NCA | national competent authority |
| NETTA | Network of National Focal Points on Travel for Transplantation |
| NFP | national focal point |
| NGS | next-generation sequencing (see also HTS) |
| NOMA | Norwegian Medical Products Agency |
| NPA | national pharmacopoeia authority |
| OCABR | Official Control Authority Batch Release |
| OCCL | official cosmetics control laboratory |
| OMCL | official medicines control laboratory |
| ONT | Organización Nacional de Trasplantes (Spanish National Transplant Organisation) |
| PaedF WP | Euroepan Paediatric Formulary Working Party |
| PaedForm | European Paediatric Formulary |
| PDG | Pharmacopoeial Discussion Group |
| PDMP | plasma-derived medicinal product |
| Ph. Eur. | European Pharmacopoeia |
| PTS | Proficiency Testing Scheme |
| rFC | recombinant factor C |
| RITTA | Registry of International Travel for Transplantation Activity |
| RPT | rabbit pyrogen test |
| RTEMIS | Real-Time Remote Inspection System |
| SoHO | substance of human origin |
| TFDA | Taiwan Food and Drug Administration |
| TNF | tumour necrosis factor |
| TOC | total organic carbon |
| TV | training visit |
| USP | United States Pharmacopeia |
| UV | ultraviolet |
| VBRN | Veterinary Batch Release Network |
| WG | working group |
| WHO | World Health Organization |
| WP | working party |